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E-mail address: sshirasa@fukuoka-u.ac.jp (S. ShiraZFAT (also known as ZNF406), originally identiﬁed as a candidate gene for autoimmune thyroid dis-
ease, encodes a zinc-ﬁnger protein, however, its function has not been elucidated. Here, we report
that human ZFAT protein is expressed in peripheral B and T lymphocytes and a human acute T lym-
phoblastic leukaemia cell line, MOLT-4 cells. Intriguing is that mouse ZFAT expression in CD4+ lym-
phocytes is increased during blast formation. Furthermore, ZFAT-knockdown in MOLT-4 induces
apoptosis via activation of caspases. These results suggested that ZFAT protein is a critical regulator
involved in apoptosis and cell survival for immune-related cells.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction dominantly expressed in thymus, spleen and lymph nodes, butZinc-ﬁnger proteins constitute one of the largest classes of pro-
tein superfamily in the mammalian genome and are involved in a
variety of cellular activities [1]. Cys2-His2 (C2H2) zinc-ﬁnger do-
mains were originally identiﬁed as DNA-binding domains, how-
ever, there are even example of zinc ﬁngers that support both
DNA and protein interactions [2,3]. Several zinc-ﬁnger proteins
such as BCL-6, BIRC5, PLZF and ZBP-89 are reported to be involved
in apoptosis via these interactions [4–8], and some of them regu-
late fundamental aspects of the immune system [9,10].
ZFAT (zinc-ﬁnger gene in autoimmune thyroid disease suscepti-
bility region; also known as ZNF406), originally identiﬁed as a can-
didate gene for autoimmune thyroid disease through linkage and
association analyses on a cohort of Japanese autoimmune thyroid
disease patients [11,12], encodes a 1243-amino-acids residue pro-
tein that contains one AT hook and 18 C2H2 zinc-ﬁnger domains
[13]. Structurally, ZFAT is assumed to bind to DNA and function
as a transcriptional regulator [13]. In mouse tissues, ZFAT is pre-chemical Societies. Published by E
une thyroid disease suscepti-
itory RNA; ZFAT-KD, ZFAT-
ell Biology, Faculty of Medi-
u, Fukuoka 814-0180, Japan.
sawa).not in other tissues including bone marrow [13].
Here, we demonstrate that human ZFAT protein is expressed in
human peripheral B and T lymphocytes and an acute T lympho-
blastic leukaemia cell line, MOLT-4 cells, and that ZFAT-knock-
down induces apoptosis via activation of caspases in MOLT-4.
These results suggested that ZFAT protein is a critical regulator in-
volved in apoptosis and cell survival.2. Materials and methods
2.1. Protein extraction
Peripheral blood was collected from consented healthy volun-
teers, separated by Ficoll gradient, and the resulting mononuclear
and leukocytes were further separated using the MACS system
with CD19 and CD3 microbeads (Miltenyi Biotec.). CD19+ lympho-
cytes, CD3+ lymphocytes, and ﬂow-through fraction, which is
mainly monocytes, were subjected to protein extraction as de-
scribed [14]. Mouse CD4+ lymphocytes separated from C57BL/6J
mouse spleens using CD4 microbeads (Miltenyi Biotec.) were stim-
ulated with combinations of immobilized anti-CD3 (1 lg/ml;
clone, 145-2C11; BD pharmingen) and anti-CD28 (5 lg/ml; clone,
37.51; BD pharmingen) antibodies in RPMI 1640 containing 10% fe-
tal calf serum at 37 C with 5% CO2.lsevier B.V. All rights reserved.
Fig. 1. Human ZFAT protein expression in human peripheral B and T lymphocytes
and a human acute T lymphoblastic leukaemia cell line, MOLT-4. Western blot
analyses for: (A) MACS-selected lymphocytes isolated from human peripheral blood
and (B) puriﬁed mouse CD4+ lymphocytes stimulated with combinations of anti-
CD3 and anti-CD28 antibodies for the indicated period. (C) The relative mRNA levels
of ZFAT in resting or activated CD4+ lymphocytes were determined by real-time
PCR. Representative data of two independent experiments in triplicates. *P < 0.001
relative to resting control. (D) MOLT-4 cells treated with ZFAT-speciﬁc or scramble
siRNAs. Afﬁnity-puriﬁed anti-ZFAT antibody was used to detect endogenous ZFAT
protein. Western blotting using anti-actin was performed as loading control (A, B
and D).
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Western blotting by anti-ZFAT or anti-actin (A2066, Sigma)
antibodies were performed as described [13,14].
2.3. Quantitative reverse transcriptase-PCR
Real-time quantitative reverse transcriptase-PCR for the mea-
surements of ZFAT mRNA levels in stimulated CD4+ lymphocytes
was performed using Absolute QPCR ROX Mix (ABgene) and Taq-
Man Gene Expression Assays (Applied Biosystems; Primer ID:
Mm01195126_m1).
2.4. Cell culture and siRNA
Human acute T lymphoblastic leukaemia cell line MOLT-4 was
cultured at 37 C with 5% CO2 in RPMI 1640 containing 10% fetal
calf serum and transfected with a small inhibitory RNA (siRNA)
using MicroPorator MP-100 (Digital Bio) according to the manufac-
turer’s instruction. Two distinct siRNAs were designed to target the
coding region of human ZFAT gene (nucleotides 200-224 and 319-
343, GenBank Accession Number NM_020863). Scrambled RNAs
containing the same number of each nucleotide as the siRNAs
targeting the ZFAT gene were used as controls. The following siRNA
duplexes (Invitrogen) were used in this study: ZFAT #1, 50-A
CGG CCA UCU UUA UGU GUA AAU GUU-30 and 50-A ACA UUU
ACA CAU AAA GAU GGC CGU-30; scramble #1, 50-A CGA CCU UUA
UGU GUA UAA UCG GUU-30 and 50-A ACC GAU UAU ACA CAU
AAA GGU CGU-30; ZFAT #2, 50-C CUU AGG CCU CUG AGU ACA
CCU GAA-30 and 50-U UCA GGU GUA CUC AGA GGC CUA AGG-30;
scramble #2, 50-C CUC CGG GUC UAU GAC CAC UAU GAA-30 and
50-U UCA UAG UGG UCA UAG ACC CGG AGG-30.
2.5. Cell proliferation assay
After transfection with ZFAT-siRNA or scramble RNA, 50000
cells were cultured in 500 ll of medium with or without 100 lM
z-VAD-fmk (R&D Systems), a broad spectrum caspase inhibitor.
Cell proliferation was measured by using a Cell Counting Kit-8
(Dojindo) according to the manufacturer’s instruction.
2.6. Flow cytometry
After transfection with ZFAT-siRNA or scramble RNA, MOLT-4
cells were ﬁxed with cold 70% ethanol for 48 h at 20 C, and
stained with 10 lg/ml of propidium iodide after treated with
1 lg/ml RNase for 1 h. The cell suspensions were then analyzed
with a ﬂuorescence-activated cell sorter (FACS-Calibur, Becton
Dickinson Co., Ltd.). Data was analyzed by CELL Quest software.
Apoptosis quantiﬁcation and detection of active CASP3 were car-
ried out with TACS Annexin V Kit (TREVIGEN) and Active CASP3
PE MAb Apoptosis Kit (BD Pharmingen), respectively, according
to the manufacturer’s instructions.
2.7. Caspase activity
Activation of CASP8 and CASP9 were detected by using Caspase-
Glo 8 Assay (Promega) and Caspase-Glo 9 Assay (Promega), respec-
tively, according to the manufacturers’ instructions. Luminescence
was measured with a GloMax 96 Microplate Luminometer
(Promega).
2.8. Statistical analysis
Data are presented as mean ± S.E.M., and statistical analysis was
performed using an unpaired Student’s t-test when comparing twogroups means. Data for the quantitative-PCR and the cell prolifer-
ation assay were subjected to one-way ANOVA and two-way ANO-
VA, respectively, and followed by post hoc Fisher’s PLSD multiple
comparisons tests. Differences at P < 0.05 were considered to be
statistically signiﬁcant.
3. Results
3.1. ZFAT protein expression in human peripheral B and T lymphocytes
We examined cell-type distribution of ZFAT protein in human
peripheral blood by western blot analysis. ZFAT was detected as
a 180 kDa protein in CD19+ and CD3+ lymphocytes, but not in the
other cell fraction (Fig. 1A), suggesting that ZFAT is predominantly
expressed in B and T lymphocytes but not in other cell types
including monocytes in human peripheral blood. This result is con-
sistent with the former analyses on ZFAT protein in mice [13].
To examine the expression level of ZFAT in activated peripheral
T lymphocytes, puriﬁed naive CD4+ T lymphocytes from mouse
spleen were stimulated with combinations of anti-CD3 and anti-
CD28 antibodies, showing that both ZFAT protein and mRNA levels
were increased after the activation compared with those of the
resting state (Fig. 1B and C). This result suggested that ZFAT will
be a key molecule for blast formation in CD4+ T lymphocytes.
3.2. Growth inhibition by ZFAT-knockdown in MOLT-4
To reveal the functions of ZFAT, ZFAT expression was inhibited
by using siRNAs and the effect of ZFAT-knockdown (ZFAT-KD) on
cellular activity in a human T lymphoblastic leukaemia, MOLT-4
cells, was examined. Treatment of MOLT-4 cells with two distinct
Fig. 2. Growth inhibition by ZFAT-knockdown in MOLT-4. (A) Cell growth of MOLT-
4 cells 24, 48 and 72 h after transfection of siRNAs for ZFAT. (B) Cell cycle analysis
by propidium iodide staining 48 h after the ZFAT-knockdown (ZFAT-KD). Repre-
sentative data of eight independent experiments. (C) Quantiﬁcations of cell
populations in sub-G1, G1, S, and G2/M phases shown in (B) determined by CELL
Quest software. n = 8; *P < 0.05; **P < 0.001 relative to scramble siRNA-treated
control; N.S., not signiﬁcant.
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ZFAT protein expression as compared to scramble RNA-treatedFig. 3. Apoptosis is induced by ZFAT-knockdown in MOLT-4. (A) Annexin V staining 24
experiments. (B) Quantiﬁcations of annexin V-positive cells shown in (A) determined by
control. (C) No induction of apoptotic cells by treatment of native cells with the conditio
for 48 h was subjected to annexin V staining. Representative data of two independent econtrols (Fig. 1D). RT-PCR analysis of ZFAT mRNA expression in
MOLT-4 cells treated with the siRNAs for ZFAT validated the spec-
iﬁcities of the siRNAs used in this study (data not shown). We
found that ZFAT-KD groups had decreased growth rates compared
with the control groups (Fig. 2A).
To assess the exact molecular mechanisms of the growth inhibi-
tion of MOLT-4 induced by ZFAT-KD, ﬂow cytoﬂuorometric analy-
sis of cell cycle by propidium iodide staining was done. Forty-eight
hours after the knockdown treatment, signiﬁcant increases in sub-
G1 phase were detected in the ZFAT-KD groups relative to the con-
trol groups, whereas the other phases, including S-, G1- and G2/M-
phases, were comparable between the groups (Fig. 2B and C). These
results suggested that ZFAT-KD in MOLT-4 cells caused cell death
and that the decreases in the cell numbers of ZFAT-KD groups ob-
served in Fig. 2A would reﬂect the differences of survival
population.3.3. Apoptosis is induced by ZFAT-knockdown in MOLT-4
To examine whether apoptosis occurs in MOLT-4 cells treated
by ZFAT-KD, ﬂow cytoﬂuorometric analysis by annexin V staining
was performed, revealing that robust productions of annexin V-po-
sitive cells were observed in the ZFAT-KD groups (Fig. 3A and B).
This result indicates that ZFAT-KD induced apoptosis in MOLT-4
cells. The apoptosis induced by ZFAT-KD was already detected at
24 h point and more evident at 48 h point after the transductions
of siRNAs (Fig. 3B). When MOLT-4 cells were exposed to the condi-
tioned medium in which ZFAT-KD cells were cultured for 48 h,
apoptotic cells were not induced (Fig. 3C), suggesting that the
ZFAT-induced apoptosis was not caused only by secretory factors
from ZFAT-KD cells.and 48 h after ZFAT-KD in MOLT-4 cells. Representative data of four independent
CELL Quest software. n = 4; *P < 0.01; #P < 0.05 relative to scramble siRNA-treated
ned medium from ZFAT-KD cells. MOLT-4 cells cultured in the conditioned medium
xperiments.
Fig. 4. CASP3, CASP8 and CASP9 are activated by ZFAT-knockdown in MOLT-4. (A) Active CASP3-staining 24 and 48 h after ZFAT-KD in MOLT-4 cells. Representative data of
four independent experiments. (B) Quantiﬁcations of active CASP3-positive cells shown in (A) determined by CELL Quest software. n = 4; *P < 0.01; #P < 0.05 relative to
scramble siRNA-treated control. (C) CASP8 (left) and CASP9 (right) activities were determined 48 h after ZFAT-KD in MOLT-4 cells. *P < 0.01 relative to scramble siRNA-treated
control.
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MOLT-4
Next, to examine the contribution of caspases in the apoptotic
event caused by ZFAT-KD in MOLT-4, ﬂow cytoﬂuorometric analy-
sis by active CASP3-staining and luminescent assays measuring
CASP8 or CASP9 activities were performed. Expectedly, CASP3
was signiﬁcantly activated in the ZFAT-KD cells (Fig. 4A and B)
and the degree of activation of CASP3 was more evident at 48 h
point than 24 h point after the transductions of siRNAs (Fig. 4B),
which is consistent with the result that annexin V-positive apopto-
tic cells gradually emerged in a time-dependent manner (Fig. 3A
and B). Furthermore, both CASP8 and CASP9 were activated upon
ZFAT-KD in MOLT-4 (Fig. 4C). These results demonstrated that
ZFAT-KD in MOLT-4 cells caused apoptosis via CASP8, CASP9 and
CASP3 activations.Fig. 5. Caspase inhibitor completely blocks growth inhibition induced by ZFAT-KD.
(A) Annexin V staining of MOLT-4 cells 24 h after transfection with siRNAs in the
presence of a caspase inhibitor, z-VAD. DMSO was used as the control. (B) Cell
growth of MOLT-4 cells 24, 48 and 72 h after transfection of siRNAs in the presence
of DMSO (left) or z-VAD (right). *P < 0.01; #P < 0.05 relative to scramble siRNA-
treated control.3.5. Caspase inhibitor completely blocks growth inhibition induced by
ZFAT-KD
Next, to conﬁrm that apoptosis upon ZFAT-KD in MOLT-4 is
mediated by caspases, ZFAT-KD cells were maintained in the pres-
ence of a caspase inhibitor, z-VAD, showing that the production of
annexin V-positive cells was signiﬁcantly attenuated (Fig. 5A) and
the difference observed in growth rate caused by ZFAT-KD was
completely diminished by the caspase inhibitor treatment
(Fig. 5B). These results showed that ZFAT-KD cells fell into apopto-
sis via activations of caspases, but not into cell cycle arrest or
reduction in cell cycle rate.
4. Discussion
We demonstrated that human ZFAT is expressed in human
peripheral B and T lymphocytes, and that mouse ZFAT expression
in T lymphocytes is increased during blast formation. Furthermore,
ZFAT-KD induces apoptosis via activation of caspases including
CASP8, CASP9 and CASP3 in MOLT-4. Taken together, ZFAT is a crit-
ical molecule in cell survival for immune-related cells and the blast
formation of naive T lymphocytes.
What is the molecular mechanism of ZFAT in cell survival for
MOLT-4? Considering the fact that both CASP8 and CASP9 are acti-
vated by ZFAT-KD in MOLT-4 (Fig. 4C), death receptor-mediated
and mitochondrial death pathways would be involved in the apop-
totic process [15–20]. Furthermore, since apoptosis by ZFAT-KD
was not reproduced only by secretory factors (Fig. 3C), not only
secretory proteins but also intracellular molecules such as death
receptor-associated proteins and cellular inhibitor of apoptosis
proteins might also play critical roles in the apoptosis. However,
the precise molecular mechanisms underlying the apoptosis by
ZFAT-KD should await further research on molecular functions of
ZFAT, especially elucidation of the direct ZFAT target sites in the
genome.
In the end, our result is the ﬁrst report demonstrating that ZFAT
is an antiapoptotic molecule and critical for cell survival in human
572 T. Fujimoto et al. / FEBS Letters 583 (2009) 568–572immune-related cells. The understanding of the molecular func-
tions of ZFAT, especially in activated lymphocytes, will shed light
on a novel gene-network in tumorigenesis and immune response,
and lead to the intervention research aimed at preventing cell
malignancies or immune-related diseases.
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